Last reviewed · How we verify

NCT03825549: REDUCE

A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing

Completed NA Last updated 6 March 2020
What this trial tests

NA trial testing Individual audit feedback in Acute Pain in 452 participants. Completed in 2 March 2020.

Timeline
3 September 2019
Primary endpoint
2 March 2020
2 March 2020

Quick facts

Lead sponsorUniversity of Pennsylvania
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposehealth services research
Enrollment452
Start date3 September 2019
Primary completion2 March 2020
Estimated completion2 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will evaluate the effect of a health system initiative aiming to change clinician opioid prescribing behaviors using two behavioral economic interventions - individual audit feedback and peer comparison feedback of clinicians.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Pain

Currently open trials in the same condition.

Other University of Pennsylvania trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03825549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing